4//SEC Filing
Powchik Peter 4
Accession 0001437749-22-015778
CIK 0001851657other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 7:54 PM ET
Size
8.0 KB
Accession
0001437749-22-015778
Insider Transaction Report
Form 4
Vaxxinity, Inc.VAXX
Powchik Peter
Director
Transactions
- Award
Stock option (right to buy)
2022-06-21+129,187→ 129,187 totalExercise: $2.09→ Class A common stock (129,187 underlying)
Holdings
- 94,186
Stock option (right to buy)
Exercise: $4.30Exp: 2032-03-31→ Class A common stock (94,186 underlying) - 225,858
Class A common stock
Footnotes (5)
- [F1]These options were automatically granted following the Issuer's annual shareholders meeting pursuant to a policy adopted by the Issuer's board of directors providing for annual non-employee director compensation.
- [F2]These options vest on the earliest of (i) the one-year anniversary of the grant date, (ii) the following year's annual stockholder meeting, and (iii) a Change in Control (as defined in the Vaxxinity, Inc. 2021 Omnibus Incentive Compensation Plan), in each case, subject to the Reporting Person's continued service with the issuer through the vesting date.
- [F3]These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates.
- [F4]These options are subject to a three-year time-vesting schedule, with 31,395 shares vesting on the first and second anniversaries of the grant date and the remainder vesting on the third anniversary of the grant date.
- [F5]The expiration date was incorrectly reported as "03/31/2022" in the Form 4 filed on April 4, 2022.
Documents
Issuer
Vaxxinity, Inc.
CIK 0001851657
Entity typeother
Related Parties
1- filerCIK 0001377247
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 7:54 PM ET
- Size
- 8.0 KB